Venous Thromboembolism Prophylaxis in Medical and Surgical ICUs in a Single University Hospital
1 other identifier
observational
1,000
1 country
1
Brief Summary
Venous thromboembolism(VTE) is the third most common cardiovascular complication among hospitalized patients, and can even cause death. VTE often occurs in intensive care patients and there had been many efforts to prevent such complication. The American College of Chest Physicians (ACCP) had published evidence-based clinical practice guideline for VTE prophylaxis. This study focuses on how VTE prophylaxis is being performed in both medical and surgical ICUs in a single University hospital, and sees the differences in such prophylactic patterns.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2013
CompletedFirst Submitted
Initial submission to the registry
April 25, 2013
CompletedFirst Posted
Study publicly available on registry
May 10, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2014
CompletedMay 5, 2014
May 1, 2014
5 months
April 25, 2013
May 2, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
number of patients prescribed with any measures of VTE prophylaxis in ICU
The object of this study is to see the percentage of ICU admitted patients prescribed with VTE prophylaxis, and analyze the adequacy of such prophylactic measure according to the international guideline. Moreover, difference between the VTE prophylaxis pattern of medical and surgical ICUs will also be seek for further analysis.
at the time of ICU admission an expected average of 5 months (When VTE prophylaxis for each patient is being ordered)
Study Arms (2)
medical ICU inpatients
surgical ICU inpatients
Eligibility Criteria
ICU admitted patients who are indicated for VTE prophylaxis.
You may qualify if:
- ICU admitted patients
You may not qualify if:
- patients under 20 years old
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Anesthesiology and Pain Medicine, Severance Hospital, Yonsei University College of Medicine
Seoul, Seoul, 120-752, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 25, 2013
First Posted
May 10, 2013
Study Start
February 1, 2013
Primary Completion
July 1, 2013
Study Completion
April 1, 2014
Last Updated
May 5, 2014
Record last verified: 2014-05